IceCure Medical Ltd. announced findings from three investigator-initiated studies of the company’s ProSense system for the ...

IceCure Medical Ltd. ("IceCure", "IceCure Medical" or the "Company"), developer of minimally-invasive cryoablation technology that destroys tumors by freezing as an alternative to surgical tumor ...

Innoblative Designs announced today that it received FDA investigational device exemption (IDE) for its Sira RFA ...

This allows delivery of high amplitude or voltage pulses that can create deeper lesions in shorter delivery ... that would routinely accompany radiofrequency ablation. Our Italian study, along ...

Introduction: Radiofrequency ablation (RFA ... with differences in the number and size of ablated lesions, the approaches to ablation (which range from percutaneous to open or laparoscopic), and the ...

Among patients with chronic rhinitis, temperature-controlled radiofrequency ablation of the posterior nasal nerve provided sustained reduction in symptoms, according to a study of 3-year follow-up ...

Surgery may not be the best next course of treatment for patients with early-stage breast cancer who had a complete response to neoadjuvant (pre-surgical) chemotherapy and standard radiation treatment ...

There were no gastric and adrenal puncture instances among patients who underwent radio-ablation in both groups. 2. Majority ...

All participants had a residual breast lesion less than two centimeters after standard chemotherapy treatment, as determined by imaging. Patients had one image-guided VACB. If no disease was ...